|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.739
|
|
|
|
protein hydroxylation
|
GO:0018126 |
4 |
0.619
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.513
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.463
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.153
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.152
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.113
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.101
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.085
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.083
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.081
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.077
|
|
|
|
membrane raft assembly
|
GO:0001765 |
3 |
0.077
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.074
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.070
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.067
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.065
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.064
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.064
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.060
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.058
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.055
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.053
|
|
|
|
peptidyl proline hydroxylation
|
GO:0019511 |
3 |
0.052
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.051
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.050
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.049
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.049
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.048
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.046
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.046
|
|
|
|
collagen biosynthetic process
|
GO:0032964 |
7 |
0.046
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.046
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.044
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.044
|
|
|
|
regulation of integrin mediated signaling pathway
|
GO:2001044 |
8 |
0.044
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.043
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.042
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.042
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.040
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.040
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.039
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.039
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.039
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.039
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.038
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.038
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.037
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.037
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.037
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.037
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.037
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.036
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.036
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.034
|
|
|
|
synaptic transmission cholinergic
|
GO:0007271 |
7 |
0.034
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.034
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.034
|
|
|
|
peptidyl proline modification
|
GO:0018208 |
6 |
0.033
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.033
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.032
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.032
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.032
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.032
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.031
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.030
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.030
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.029
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.028
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.028
|
|
|
|
localization within membrane
|
GO:0051668 |
4 |
0.027
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.027
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.027
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.026
|
|
|
|
positive regulation of interleukin 6 secretion
|
GO:2000778 |
1 |
0.026
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.026
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.026
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.026
|
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.026
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.026
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.025
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.025
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.025
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.024
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.024
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.024
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.024
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.024
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.024
|
|
|
|
peripheral nervous system axon regeneration
|
GO:0014012 |
2 |
0.023
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.023
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
26 |
0.023
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.023
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.023
|
|
|
|
peptidyl proline hydroxylation to 4 hydroxy l proline
|
GO:0018401 |
2 |
0.023
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.022
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.022
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.022
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.022
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.022
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.022
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.022
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.022
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.021
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.021
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.021
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.021
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.021
|
|
|
|
oligosaccharide biosynthetic process
|
GO:0009312 |
7 |
0.020
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.020
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.020
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.020
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.020
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.020
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.020
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.019
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.019
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.019
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.019
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.019
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.019
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.019
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.019
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.019
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.018
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.018
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.018
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.018
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.018
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.018
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.018
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.018
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.018
|
|
|
|
early endosome to late endosome transport
|
GO:0045022 |
2 |
0.017
|
|
|
|
regulation of sphingolipid biosynthetic process
|
GO:0090153 |
1 |
0.017
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.017
|
|
|
|
protein heterotrimerization
|
GO:0070208 |
8 |
0.017
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.017
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.017
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.017
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.017
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.017
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.017
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.017
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.017
|
|
|
|
negative regulation of type b pancreatic cell apoptotic process
|
GO:2000675 |
3 |
0.017
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.017
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.016
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.016
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.016
|
|
|
|
copii coated vesicle budding
|
GO:0090114 |
2 |
0.016
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.016
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.016
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.016
|
|
|
|
4 hydroxyproline metabolic process
|
GO:0019471 |
5 |
0.016
|
|
|
|
extracellular fibril organization
|
GO:0043206 |
2 |
0.016
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.016
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.016
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.016
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.016
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.016
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.016
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.015
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.015
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.015
|
|
|
|
protein heterooligomerization
|
GO:0051291 |
14 |
0.015
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.015
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.015
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.015
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.015
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.015
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.015
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.015
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.015
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.015
|
|
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.014
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.014
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.014
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.014
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.014
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.014
|
|
|
|
golgi vesicle transport
|
GO:0048193 |
30 |
0.014
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.014
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.014
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.014
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.014
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.014
|
|
|
|
integrin biosynthetic process
|
GO:0045112 |
1 |
0.014
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.014
|
|
|
|
protein folding
|
GO:0006457 |
28 |
0.014
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.014
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.014
|
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.014
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.014
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.014
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.014
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.014
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.014
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.013
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.013
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.013
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.013
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.013
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.013
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.013
|
|
|
|
collagen metabolic process
|
GO:0032963 |
17 |
0.013
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.013
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.013
|
|
|
|
notochord development
|
GO:0030903 |
20 |
0.013
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.013
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.013
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.013
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.013
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.013
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.013
|
|
|
|
chondroblast differentiation
|
GO:0060591 |
2 |
0.013
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.013
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.013
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.013
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.013
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.013
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.013
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.012
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.012
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.012
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.012
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.012
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.012
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.012
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.012
|
|
|
|
multi organism reproductive behavior
|
GO:0044705 |
29 |
0.012
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.012
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.012
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.012
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.012
|
|
|
|
response to organophosphorus
|
GO:0046683 |
22 |
0.012
|
|
|
|
multicellular organismal catabolic process
|
GO:0044243 |
7 |
0.012
|
|
|
|
cellular water homeostasis
|
GO:0009992 |
2 |
0.012
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.012
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.012
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.012
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.012
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.012
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.012
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.012
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.012
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.011
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.011
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.011
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.011
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.011
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.011
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.011
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.011
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.011
|
|
|
|
antibacterial peptide secretion
|
GO:0002779 |
1 |
0.011
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.011
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.011
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.011
|
|
|
|
regulation of ceramide biosynthetic process
|
GO:2000303 |
1 |
0.011
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.011
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.011
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.011
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.011
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.011
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.011
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.011
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.011
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.011
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.011
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.011
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.011
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.011
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.011
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.011
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.011
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.011
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.011
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.010
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.010
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.010
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.010
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.010
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.010
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.010
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.010
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.010
|
|
|
|
negative regulation of macrophage chemotaxis
|
GO:0010760 |
1 |
0.010
|
|
|
|
t cell mediated cytotoxicity
|
GO:0001913 |
26 |
0.010
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.010
|
|
|
|
intussusceptive angiogenesis
|
GO:0002041 |
2 |
0.010
|
|
|
|
negative regulation of anoikis
|
GO:2000811 |
2 |
0.010
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.010
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.010
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.010
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.010
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.010
|
|